Results 171 to 180 of about 163,713 (265)

A Tale of Two Pathways: Same‐Surgeon Versus Different‐Surgeon Resection After Second Surgical Opinion

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background The role of second surgical opinions (SSOs) in gastrointestinal (GI) cancer care is not well‐defined. While SSOs are common, the impact may depend on whether patients ultimately undergo resection with the same surgeon or with a different surgeon after the SSO.
Areesh Mevawalla, Selamawit Woldesenbet, Azza Sarfraz, Qaidar Alizai, Meher Angez, Abdulaziz Elemosho, Odysseas P. Chatzipanagiotou, Timothy M. Pawlik   +7 more
wiley   +1 more source

Gut Microbiome-Metabolite Interactions Contribute to Esophageal Cancer Risk: Evidence From Mendelian Randomization and Multiomics Integration. [PDF]

Int J Genomics
Yang H, Liu Y, Zhu T, Xiao Z, Wang H, Zhu S, Chen Y.   +6 more
europepmc   +1 more source

Institutional Learning Curve in Esophagectomy: Technical Standardization of Gastric Conduit Formation and Conduit‐Related Outcomes in 187 Consecutive Patients

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background Learning curves in esophagectomy are often described in terms of procedural volume, but institutional maturation also reflects progressive standardization of reconstruction, operative choreography, and team‐based decision‐making.
Mayank Tripathi, Reshma R. Balachandran, Kumar Vineet, Dhaval Vadodaria, Vaibhav Kushwaha, Mohd Irfan Ansari, Piyush Shukla   +6 more
wiley   +1 more source

The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer. [PDF]

J Cardiothorac Surg
Chiu CH, Lin J, Zhang P, Chang AC, Derstine BA, Ross BE, Enchakalody B, Shah NV, Liu YH, Wang SC, Chao YK.   +10 more
europepmc   +1 more source

Pyoderma Gangrenosum: A Retrospective Cohort Study of Comorbidities and Therapies in Over 65,000 Patients in the TriNetX Database

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis associated with systemic inflammatory diseases and malignancy. Although biologic therapies demonstrate efficacy in PG, the extent of their real‐world use remains incompletely characterized.
Rhiannon Grange, Tara Sholji, Marra Aghajani, Cindy Kok, John Frew   +4 more
wiley   +1 more source

Sarcopenia in esophageal cancer: from passive prognostic marker to active treatment target. [PDF]

J Gastrointest Oncol
Park JS, Laurence JM, Leibman S, Falk GL, Smith G, Sandroussi C.   +5 more
europepmc   +1 more source

Andrographolide Modulates Fibrogenic and Oxidative Stress Responses in Human Lung Fibroblasts

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Pulmonary fibrosis is a progressive lung disorder characterized by fibroblast activation and excessive extracellular matrix deposition. Andrographolide (ANDRO) has been reported to attenuate pulmonary fibrosis, but the underlying molecular mechanisms remain incompletely understood.
Yu‐Hsin Tseng, Yen‐Hsien Wu, Yi‐Ching Liu, I‐Chen Chen, Chung‐Yu Yeh, Shang‐En Huang, Ren‐Long Jan, Jwu‐Lai Yeh, Jong‐Hau Hsu   +8 more
wiley   +1 more source

Dental Health and Survival Following Surgery for Esophageal Cancer. [PDF]

Ann Surg Oncol
Buchli K, Gottlieb-Vedi E, Mattsson F, Wiström E, Klinge B, Lagergren P, Lagergren J.   +6 more
europepmc   +1 more source

WDR72 Drives Esophageal Squamous Cell Carcinoma Progression by Inhibiting Autophagy via the PI3K/Akt/mTOR Pathway

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with a high rate of recurrence and metastasis, necessitating the identification of novel therapeutic targets. WD repeat‐containing protein 72 (WDR72) has been linked to various cancers, but its specific biological function and underlying mechanism in ESCC remain largely ...
Hao Wu, Zhong‐Xiang Jiang, Zheng Jiang
wiley   +1 more source

Combined organ resection for esophageal cancer invading adjacent organs is becoming a safe and curative procedure. [PDF]

J Thorac Dis
Nakajima M, Kojima K.
europepmc   +1 more source